The capsid sequences of the three SIVsmE660 clones were aligned and compared to SIVsmE543-3, which was sensitive to both the TRIM5TFPand TRIM5Cypalleles in our previous studies

The capsid sequences of the three SIVsmE660 clones were aligned and compared to SIVsmE543-3, which was sensitive to both the TRIM5TFPand TRIM5Cypalleles in our previous studies. are susceptible to resistance by common rhesus macaque TRIM5 alleles and result in reduced virus acquisition and replication in macaques that express these restrictive alleles. We previously observed that spontaneous variations in the capsid gene were associated with improved replication in macaques, and the introduction of two amino acid changes in the capsid transfers this improved replication to the parent clone. In the present study, we introduced these mutations into a related but distinct strain of SIV that is commonly used for challenge studies for vaccine trials. These mutations also improved the replication of this strain in macaques with the restrictive TRIM5 genotype and thus Abiraterone metabolite 1 will eliminate the confounding effects of TRIM5 in vaccine studies. == INTRODUCTION == Simian immunodeficiency virus (SIV)-infected rhesus macaques are widely used as an animal model to evaluate the efficacy of vaccine strategies against human immunodeficiency virus (HIV)/AIDS (13). Macaques infected with SIV Abiraterone metabolite 1 develop disease progression remarkably similar to that with human AIDS, including acute robust and chronic persistent viral replication, progressive loss of CD4 T cells, immunodeficiency, and opportunistic infections (4). Similarly to HIV infections in humans, the clinical outcomes for SIV-infected rhesus macaques are variable. For SIV-infected rhesus macaques, this variability is at least partially due to host genetic differences, including major histocompatibility complex class I (MHC-I) and TRIM5 protein polymorphisms (512). TRIM5 was first identified as a restriction protein responsible for the inhibition of HIV-1 replication in macaque cell lines (13, 14). It is found in all mammals and acts as a cross-species restriction factor that inhibits retroviral infection (1320). Recently, we and several other groups reported that TRIM5 polymorphisms common among Indian rhesus macaques affected virus replication and clinical outcomes following SIV infection. Based on an insertion/deletion polymorphism at amino acids 339 to 341 in the B30. 1/SPRY domain of TRIM5 and associated differences in inhibitory activity against SIV strains, three functional types of TRIM5 alleles can be identified, TRIM5Q, TRIMTFP, and TRIMCypA(21, 22). Of the three alleles, TRIM5Qis permissive and TRIMTFPand TRIMCypAare restrictive for SIVsm replication. In Rabbit Polyclonal to ROCK2 SIVsmE543-3-infected rhesus macaque cohorts, viral loads in animals with restrictive TRIM5TFP/TFPand TRIM5TFP/CypAgenotypes were 2 to 3 logs lower than those in macaques with at least one permissive TRIM5Qallele (79). A modest association of viral loads and TRIM5 genotypes (excluding TRIM5CypA-expressing macaques) was observed in a cohort of rhesus macaques infected with SIVmac251, but the magnitude was Abiraterone metabolite 1 considerably lower than what we observed in SIVsmE543-3-infected cohorts (11). This TRIM5 effect on SIVmac251 has since been questioned by conflicting results from other vaccine studies using this virus (23). The presence of restrictive TRIM5 genotypes also decreased the mucosal transmission of uncloned SIVsmE660 (E660) but had no effect on SIVmac239 in repeated low-dose inoculations in rhesus macaques (24, 25). These results indicated that rhesus TRIM5 polymorphisms may confound vaccine study results, especially when uncloned SIVsmE660 is used as the challenge strain. The current approach to avoiding confounding TRIM5 effects has been to exclude macaques with restrictive TRIM5 genotypes by genetic screening or balancing groups for TRIM5 genotype. However , this greatly increases the cost and logistics of these studies since more than 50% of rhesus macaques have restrictive TRIM5 genotypes (7). In the present study, we generated Abiraterone metabolite 1 TRIM5-resistant SIVsmE660 variants that can overcome TRIM5 restriction. We previously reported that the closely related infectious molecular clone SIVsmE543-3 escaped from TRIM5 restriction when passaged in rhesus macaques expressing two restrictive TRIM5 alleles. Two single amino acid substitutions (P37S and R98S) and amino acid substitutions 87 to 91 in the CypA binding loop (GPLPA) in the capsid region were identified as being associated with escape from restriction by the TRIM5TFPand TRIM5Cypalleles, respectively (8). We introduced these mutations into SIVsmE660 clones and evaluated one clone in rhesus macaques with different TRIM5 genotypes. == MATERIALS AND METHODS == == Animal care..